LG
Ligand Pharmaceuticals, Inc.
LGNZZ · OTC
$0.07 -7.14% (-$0.01)
1M -14.29%
Market Cap $1.30M
P/E Ratio 0.01x
Div. Yield -
ROE 20.06%
Bulios Fair Price
$0.09
38.5% upside
Trenutna cena
$0.065
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LGNZZ trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 0.01x
EV/EBITDA 0.74x
P/S 0.00x
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
100 /100
Strong Gross margin 90.70%
Net margin 67.88%
Op. margin 34.45%
Quality
49 /100
Average ROIC 3.88%
ROE 20.06%
ROA 9.02%
Debt
81 /100
Low Debt/Equity 1.16x
Current ratio 30.49x
Int. coverage 51.04x
Stability
91 /100
Stable Beta 0.98x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LGNZZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report